CD52-directed Antibody Interactions
- Name
- CD52-directed Antibody Interactions
- Accession Number
- DBCAT004258
- Description
Not Available
- Drugs
Drug Drug Description Alemtuzumab A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. - Drugs & Drug Targets